Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Regulatory Filings 2021

Nov 26, 2021

62142_rns_2021-11-26_e00bb05a-189b-493b-ab52-659164a4de60.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

·t· Marksans Pharma Ltd.

BSE Limited

Corporate Relation Department PhirozeJeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404

National Stock ExchangeofIndia Limited Listing Department Exchange Plaza, C-l, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai -400051. Syrnbol:MilRJ(S)~S

Sub: Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish details of issue of duplicate of share certificate as given hereinbelow on ~ ovember 26, 2021 :

==> picture [456 x 105] intentionally omitted <==

----- Start of picture text ----- Sr. Folio Name of the Old Share New Share Share No. ofNo. No. Shareholders Certificate Certificate Distinctive SharesNo. No Nos. From-To1.)\001070 )\ditya Saran 49 1094 1080001- 10001081000----- End of picture text -----

Yours faithfully, For Marksans Pharma Limited

jJ())M5~C -::-:-

.-::-:-

,.. Harshavardhan Panigrahi Compan1'" Secretary

Marksans Pharma Ltd.

~ 1~~FI.oor,"GRAND.EUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara n en (W), Mumbal - 400 053 • Tel.: +91 224001 2000 • E-mail: [email protected]~ www.marksanspharma.com